Quantcast

Latest Prostate cancer Stories

2014-09-08 12:28:32

OWINGS MILLS, Md., Sept. 8, 2014 /PRNewswire-USNewswire/ -- Chesapeake Urology, the largest urology practice in the mid-Atlantic and one of the leading urology groups in the nation, is sponsoring its 8(th) Annual ZERO Prostate Cancer Challenge/Baltimore (ZPCC) on Sunday, September 14, 2014 during Prostate Cancer Awareness Month. The event will be held at Towson University's Johnny Unitas Stadium in Towson, MD. Dr. Sanford J. Siegel, President and CEO of Chesapeake Urology,...

2014-09-08 08:31:12

Patients also report significant impact on mood and career WASHINGTON, Sept. 8, 2014 /PRNewswire/ -- A recent survey conducted by ZERO - The End of Prostate Cancer and Ferring Pharmaceuticals Inc. aimed to uncover the impact of prostate cancer on patients, their caregivers, and the healthcare professionals (HCPs) that support them. The majority (64 percent) of patients surveyed report that their prostate cancer diagnosis has a moderate to severe impact on their social and emotional wellbeing....

2014-09-08 08:31:01

BETHESDA, Md., Sept. 8, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Linda F. Powers, CEO, will present at 2:05 pm on Tuesday, September 9, 2014, in the Holmes I Salon at the Palace Hotel in New York as part of the Rodman & Renshaw 16(th) Annual Global Investment Conference. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO...

2014-09-05 23:00:54

Eleven-month Increase in Median OS Reported with VT-122 plus Sorafenib, Compared to Sorafenib Alone. Data Presented at International Liver Cancer Association Conference. MORRISTOWN, N.J (PRWEB) September 05, 2014 Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, announced positive results from a Phase II randomized, open-label, controlled clinical trial of its lead compound, VT-122, in combination with...

2014-09-04 12:26:30

Dr. Drew Pinsky's personal battle with prostate cancer inspires him to join forces with PCF SANTA MONICA, Calif., Sept. 4, 2014 /PRNewswire-USNewswire/ -- The Prostate Cancer Foundation (PCF) announced that Drew Pinsky, MD has been elected to the Board of Directors. "Drew has valuable experience in internal and addiction medicine," said Jonathan W. Simons, MD, president and CEO of PCF. "As one of approximately 16 million prostate cancer survivors worldwide, Drew brings personal...

2014-09-04 08:30:46

Pennsylvania physicians say beating it begins with communications HARRISBURG, Pa., Sept. 4, 2014 /PRNewswire-USNewswire/ -- The simple fact of life for men is that as they age the risk of prostate cancer increases. And, it's one of those things that men cringe about. Statistics from the Centers for Disease Control and Prevention (CDC) show increasing risk as men age from their 50s into their 60s and then 70s. With the exception of skin cancer, the CDC says prostate cancer is the most common...

2014-09-04 08:30:38

New additions to PowerLook AMP provide radiologists a consistent, standardized way to evaluate performance of breast imaging systems in real time NASHUA, N.H., Sept. 4, 2014 /PRNewswire/ -- iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that, in addition to Volpara(®)Density((TM)) volumetric breast density assessment software,...

2014-09-04 08:29:31

LINCOLNSHIRE, Ill., Sept. 4, 2014 /PRNewswire/ -- TOLMAR Pharmaceuticals, Inc., focused on specialty pharmaceutical products, is partnering with the not-for-profit organization ZERO - The End of Prostate Cancer in a series of events this fall that will bring together cancer survivors, healthcare providers, family, friends, athletes, and businesses united in their desire to fight prostate cancer. TOLMAR Pharmaceuticals is participating in the 26+ run/walk events hosted by ZERO...

2014-09-03 08:32:58

Prostate Cancer Awareness Month in September Promotes Importance of Early Detection to Save Men's Lives MELVILLE, N.Y., Sept. 3, 2014 /PRNewswire/ -- Henry Schein Cares, the global corporate social responsibility program of Henry Schein, Inc., and the Large Urology Group Practice Association (LUGPA) have partnered again this year to raise awareness among families across the country about the importance of putting prostate cancer check-ups on the calendar for the men in their lives....

2014-09-03 08:27:14

Innovative Urolift procedure for treatment of BPH in men has minimal side effects NEW YORK, Sept. 3, 2014 /PRNewswire-USNewswire/ -- Symptoms of enlarged prostate affect millions of men, who suffer needlessly from frequent urination and difficulty emptying their bladder. Urinary tract obstruction from BPH can cause dangerous bladder problems in men including urinary retention, UTI and kidney failure. http://photos.prnewswire.com/prnvar/20140408/NY00250LOGO According to Dr. Alex...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.